Pharmaco-epidemiology plays a role of increasing importance in the field of drug safety and regulatory decision making. On the one hand, the introduction of computers into clinical practice facilitates the performance of large-scale cohort studies and nested case-control studies. On the other hand, it creates some problems regarding the quality of outcome and exposure assessment. Because the commercial consequences of pharmaco-epidemiological studies may be enormous, discussions in this area may be heated.
In this course, referring to established drug safety problems will highlight some of the complex aspects of outcome and exposure assessment in pharmaco-epidemiology.
Objective
- Understanding the complex aspects of outcome and exposure assessment in pharmaco-epidemiology.